Pharmabiz
 

IPA to organize its third convention in Mumbai

Our Bureau, MumbaiTuesday, July 1, 2003, 08:00 Hrs  [IST]

The Indian Pharmaceutical Association (IPA) is organizing its third convention in Mumbai from September 14 to 16, 2003. The theme of the convention is “Destination India-Global Pharma Business”. The objective of the convention is to project India as a manufacturing centre for quality APIs and pharmaceutical products. The two-day conference and exhibition are expected to provide a comprehensive picture of India’s capabilities and potential. Nearly 300 participants from all over India and 200 from abroad are expected to participate in the convention. Dr.Vinod Shah, president of American Association Pharmaceutical Sciences will speak on “cGMP for the 21st Century” during this event. The conference sessions will be preceded by a pre-convention on Sept 14 on ICH-Q7A guidelines issued in August 2001. The intense one-day pre convention will explain the guidelines, outline specifically what is expected from manufacturers and present pragmatic ideas for ICH-Q7A implementation.

PROGRAMME

Date: 14th September 2003 : Pre - convention

Date: 15th September 2003 : Regulated Market

Date: 16th September 2003 : Non Regulated   Market

DAY ONE : Regulated Market
Morning Session

Session No.

     Time           Topic                Speaker
  8.45 - 9.15

Registration

 
Session 1 9.15 - 10.15

Techno-commercial strategy for marketing in developed countries

Mr. Gautam Kumra Principal,
McKinsey & Company, INDIA
Session 2 10.15 - 11.15

cGMPs for 21st century

Dr. Vinod Shah
President,
American Association of Pharmaceuticals Scientists (AAPS), USA

  11.15 - 11.30

Tea break

 
Session 3 11.30 - 12.30

Advancement in Pharmaceutical Technology

Mr. Hari Fluora President ,
Applied Containment Engineering, Inc., USA
  12.30 - 1.30

Lunch break

 

Afternoon Session

Session 4 1.30 - 2.30

India - An Emerging Pharmaceutical Powerhouse

Dr. Ajit Dangi
Director General,
Organisation of Pharmaceutical Producers of India (OPPI), INDIA

Session 5 2.30 - 3.15

Opportunities - Target India

Dr. Denis Croisat
Director, API outsourcing,
Aventis Pharma, GERMANY

  3.15 - 3.30

Tea break

 
Session 6 3.30 - 4.15

Clinical Trials : Opportunities in clinical research and contract research in India

Dr Mohan Beltangdy Vice President,
Pfizer Global Research,
Pfizer Inc., USA

 DAY TWO : Non Regulated Market
Morning Session

Session No.

Time Topic Speaker
Session 1 9.30 - 10.30

Strategy for International markets : Business potential, Barriers and challenges

Mr. D. S. Brar
Managing Director,
Ranbaxy Laboratories Ltd.,
INDIA

Session 2 10.30 - 11.15

"Global" Indian Pharmaceutical Company - a success story

Dr. Rajendra Agarwal
Managing Director,
Mcleods Pharmaceuticals Ltd., INDIA

  11.15 - 11.30

Tea break

 
Session 3 11.30 - 12.30

Sourcing APIs from India - Opportunities and challenges

Mr. Venkat Jasti
Managing Director,
Suven Pharmaceuticals Ltd.,
INDIA

  12.30 - 1.30

Lunch break

 

Afternoon Session

Session 4 1.30 - 2.30

Intellectual Property Rights : Challenges and Opportunities

Mr. Divaakar
Managing Director,
Ace Global, INDIA

Session 5 2.30 - 3.30

Counterfeiting - International perspective

Dr. Michael Anisfeld
Globepharm, USA

  3.30 - 3.45

Tea break

 
Session 6 3.45 - 4.45

Panel Discussion
India Inc. SWOT analysis

Mr. Ashwini Kumar
Mr. Ajit Singh
Mr. D. G. Shah

 For Registration etc. contact : ipaconvention@ipaconvention.com

 
[Close]